Skip to main content
KBS_Icon_questionmark link-ico

Centre for Rheumatic Disease

 

 

A European Alliance of Associations for Rheumatology (EULAR) Centre of Research Excellence, the centre brings together clinicians, scientists and people living with rheumatic disease to translate discovery into improvements in care.

Our footprint spans two King’s campuses – Guy’s and Denmark Hill – together with our partner hospitals (Guy’s & St Thomas’ NHS Foundation Trust and King’s College Hospital NHS Foundation Trust). Across these settings we integrate:

  • Translational medicine laboratories delivering bench immunology, cellular & molecular profiling and pre‑clinical therapeutic evaluation.
  • Data‑science and epidemiology teams harnessing population‑scale resources such as OpenSAFELY to map care quality, disease burden and long‑term outcomes.
  • Early‑ to late‑phase clinical‑trial infrastructure supporting investigator‑initiated and industry‑sponsored studies – including first‑in‑human CAR‑T‑cell therapy for refractory lupus and dermatomyositis.
  • A dedicated Patient Partnership Group that co‑creates every project – from identifying unmet need, through protocol design, to analysing, reporting and sharing results.

Diseases we study

  • Inflammatory arthritis (rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis)
  • Systemic lupus erythematosus (SLE) and inflammatory myopathies including dermatomyositis
  • Vasculitides (ANCA‑associated, large‑vessel and others)
  • Autoimmune driven interstitial lung disease
  • Sarcoidosis
  • VEXAS syndrome
  • IgG4‑related disease
  • Other orphan connective‑tissue and musculoskeletal disorders

Our methodologies

  • Quantitative: trials, large observational cohorts, registry analyses (e.g. BSRBR, NEIAA), genomics, multi‑omics and real‑world evidence studies.
  • Qualitative: mental‑health, psychosocial and health‑services research exploring lived experience and barriers to care.

 

News and events